Shukra Pharmaceuticals Limited (BOM:524632)
India
· Delayed Price · Currency is INR | Market Cap | 9.09B |
| Revenue (ttm) | 367.94M |
| Net Income (ttm) | 95.75M |
| Shares Out | 437.88M |
| EPS (ttm) | 0.22 |
| PE Ratio | 94.32 |
| Forward PE | n/a |
| Dividend | 0.10 (0.48%) |
| Ex-Dividend Date | Sep 23, 2024 |
| Volume | 55,611 |
| Average Volume | 185,499 |
| Open | 20.75 |
| Previous Close | 20.35 |
| Day's Range | 20.75 - 20.75 |
| 52-Week Range | 5.75 - 27.15 |
| Beta | 0.26 |
| RSI | 84.52 |
| Earnings Date | Aug 12, 2025 |
About Shukra Pharmaceuticals
Shukra Pharmaceuticals Limited develops, manufactures, markets, and exports various drugs and dosage forms in India and internationally. Its product portfolio includes macrolides, quinolones, anti-bacterial, anti-fungal, anti-malarial, anti-viral, anti-protozoal, anti-anthelmintic, sedative and tranquillizer, anti-depressant, anti-manic, anti-emetic, anti-ulcer, beta blockers, diuretics, analgesic, muscle relaxants, anti tuberculosis, vitamin products, anti allergics, corticosteroids, hyper and hypoglycemic, and other products, as well as antib... [Read more]
Financial Performance
In 2024, Shukra Pharmaceuticals's revenue was 367.94 million, a decrease of -51.88% compared to the previous year's 764.66 million. Earnings were 95.75 million, a decrease of -48.35%.
Financial StatementsNews
Shukra Pharmaceuticals rises nearly 2% as company opens four new branch offices
Shares of Shukra Pharmaceuticals Limited rose nearly 2% to ₹19.57 today after the company announced the opening of four new branch offices in major Indian cities — Mumbai, Gurgaon (NCR), Bangalore, an...
Shukra Pharmaceuticals opens new branch offices in Mumbai, Gurgaon, Bangalore, and Kolkata to boost market reach
Shukra Pharmaceuticals Limited announced the opening of four new branch offices in key Indian cities — Mumbai, Gurgaon (NCR), Bangalore, and Kolkata — as part of its strategic growth initiative aimed ...
Shukra Pharmaceuticals shares surge 90% in past one month; Check details
Shukra Pharmaceuticals has witnessed a dramatic surge in its stock price, rising by an impressive 90% in the past month. As of January 24, 2025, the stock closed at 224.60. Performance Breakdown: Shuk...
Shukra Pharmaceuticals shares surge 166% in past one month; Check details
Shukra Pharmaceuticals has witnessed a remarkable surge in its stock price, with shares rising by an astounding 166% over the past month. As of January 10, 2025, the stock closed at ₹184.45, marking a...